P. Kroboth

发表

477. Characterizing the diurnal rhythm of DHEA and effects of an oral dose of alprazolam

E. Erosheva, F. Salek, R. Stone, 2000, Biological Psychiatry.

Paroxetine-induced hyponatremia in older adults: a 12-week prospective study.

B. Pollock, B. Mulsant, C. Reynolds, 2004, Archives of internal medicine.

Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.

P. Kroboth, R. Dockens, D. Salazar, 1995, Journal of clinical psychopharmacology.

Tolerance to alprazolam after intravenous bolus and continuous infusion: Psychomotor and EEG effects

P. Kroboth, R. Erb, Randall B. Smith, 1988, Clinical pharmacology and therapeutics.

Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping

P. Kroboth, John W. Wilson, R. Frye, 2002, Clinical pharmacology and therapeutics.

Single-dose pharmacokinetics of clomiphene citrate in normal volunteers.

P. Kroboth, P. Manberg, L. Dittert, 1986, Fertility and sterility.

Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics

P. Kroboth, D. Wender, Randall B. Smith, 1984, Clinical pharmacology and therapeutics.

Triazolam pharmacokinetics after intravenous, oral, and sublingual administration.

P. Kroboth, R. Bertz, F. Kroboth, 1995, Journal of clinical psychopharmacology.

Characterizing the Diurnal Rhythm of DHEA

E. Erosheva, P. Kroboth, J. Greenhouse, 2002 .

DHEA and DHEA‐S: A Review

F. Salek, P. Kroboth, A. Pittenger, 1999, Journal of clinical pharmacology.

Paroxetine-Induced Hyponatremia in Older Adults

B. Pollock, B. Mulsant, C. Reynolds, 2016 .

Paroxetine-Induced Hyponatremia in the Elderly due to the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)

B. Pollock, B. Mulsant, C. Reynolds, 2003, Journal of geriatric psychiatry and neurology.

Clonazepam and sertraline: absence of drug interaction in a multiple-dose study.

P. Bonate, P. Kroboth, E. Suárez, 2000, Journal of clinical psychopharmacology.

Triazolam protein binding and correlation with alpha‐1 acid glycoprotein concentration

P. Kroboth, R. Rault, Randall B. Smith, 1984 .

Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET.

P. Kroboth, R. Ferrell, S. Riechman, 2004, Physiological genomics.

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.

P. Kroboth, R. Barbhaiya, U. Shukla, 1995, Journal of clinical psychopharmacology.

ARE DHEA AND/OR DHEA-S CONCENTRATIONS ASSOCIATED WITH REMISSION OF DEPRESSION OR IMPROVEMENTS IN MENTAL STATUS SCORES IN OLDER ADULTS?

A. M. Linares, B. Pollock, B. Mulsant, 1999 .

The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies

F. Salek, P. Kroboth, K. Bigos, 2002, Journal of clinical pharmacology.

Modulation of [3H]flunitrazepam binding by natural and synthetic progestational agents

P. Kroboth, I. Reynolds, D. Stiff, 1993, Pharmacology Biochemistry and Behavior.

Effect of neuroactive steroids on [3H]flumazenil binding to the GABAA receptor complex in vitro

P. Kroboth, I. Reynolds, R. Bertz, 1995, Neuropharmacology.

Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women.

P. Kroboth, I. Reynolds, F. Kroboth, 1995, Journal of clinical psychopharmacology.

Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.

P. Kroboth, J. Puschett, R. Rault, 1985, British journal of clinical pharmacology.

Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion.

P. Kroboth, J. Weiss, A. Greenberg, 1984, The American journal of medicine.

Sex Differences in the Pharmacokinetics of Dehydroepiandrosterone (DHEA) after Single‐ and Multiple‐Dose Administration in Healthy Older Adults

F. Salek, R. Stone, P. Kroboth, 2000, Journal of clinical pharmacology.

Alprazolam increases dehydroepiandrosterone concentrations.

F. Salek, R. Stone, P. Kroboth, 1999, Journal of clinical psychopharmacology.

Simplified procedure for measurement of serum dehydroepiandrosterone and its sulfate with gas chromatography-ion trap mass spectrometry and selected reaction monitoring.

P. Kroboth, M. Zemaitis, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration

P. Kroboth, J. P. Phillips, J. Vanderlugt, 2004, Psychopharmacology.

Triazolam (Halcion, the Upjohn Company)

P. Kroboth, R. Juhl, 1983 .

Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis.

P. Kroboth, R. Rault, M. McNeil, 1983, Archives of internal medicine.

Nighttime Dosing of Triazolam in Patients with Liver Disease and Normal Subjects: Kinetics and Daytime Effects

P. Kroboth, Randall B. Smith, D. Thiel, 1987, Journal of clinical pharmacology.

Temporal Variation in Triazolam Pharmacokinetics and Pharmacodynamics After Oral Administration

P. Kroboth, J. P. Phillips, R. Smith, 1986, Journal of clinical pharmacology.

Pharmacodynamic evaluation of the benzodiazepine–oral contraceptive interaction

P. Kroboth, G. Stoehr, R. Juhl, 1985, Clinical pharmacology and therapeutics.

Oral Administration of Micronized Progesterone: A Review and More Experience

P. Kroboth, F. Kroboth, J. McAuley, 1996, Pharmacotherapy.

Pharmacodynamics of Triazolam After Intravenous Administration

P. Kroboth, P. D. Varner, R. Smith, 1987, Journal of clinical pharmacology.

Alprazolam in End‐Stage Renal Disease: I. Pharmacokinetics

P. Kroboth, B. Piraino, V. Schmith, 1991, Journal of clinical pharmacology.

Decreasing Pain and Anxiety Associated with Patient‐Activated Atrial Shock: A Placebo‐Controlled Study of Adjunctive Sedation with Oral Triazolam

B. Pollock, P. Kroboth, D. Schwartzman, 2006, Journal of cardiovascular electrophysiology.

Time-dependent sensitization to triazolam? An observation in three studies.

P. Kroboth, J. McAuley, C. Derry, 1995, Journal of clinical psychopharmacology.

Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.

R B Smith, P. Kroboth, A. Pittenger, 1995, Journal of clinical psychopharmacology.

Basic Concepts in Pharmacodynamic Modeling

Terry L. Schwinghammer, Patricia D. Kroboth, P. Kroboth, 1988, Journal of clinical pharmacology.

Hepatotoxieity and Erythromycin

P. Kroboth, T. Schwinghammer, 1980 .

Adverse Effects of Risperidone on Eye Movement Activity: A Comparison of Risperidone and Haloperidol in Antipsychotic-Naive Schizophrenic Patients

J. Sweeney, M. Keshavan, P. Kroboth, 1997, Neuropsychopharmacology.

Pharmacokinetics of the Newer Benzodiazepines

P. Kroboth, P. Garzone, 1989, Clinical pharmacokinetics.

Mechanism for the interaction between triazolam and cimetidine.

P. Kroboth, S. Cox, P. Anderson, 1986, Biopharmaceutics & drug disposition.

Core Competencies for Research Training in the Clinical Pharmaceutical Sciences

Robert R Bies, P. Kroboth, T. Nolin, 2011, American Journal of Pharmaceutical Education.

Central Issues Relevant to Clinical Pharmaceutical Scientist Training Programs

P. Kroboth, R. Blouin, T. Ludden, 1991, Pharmacotherapy.

Pharm.D. Pathways to Biomedical Research: The National Institutes of Health Special Conference on Pharmacy Research

P. Kroboth, H. McLeod, W. Figg, 2008, Pharmacotherapy.

Graduate Education and Research at the University of Pittsburgh (GEAR-UP): A Program to Educate Students about Pharmaceutical Research

P. Kroboth, S. Poloyac, J. Janjic, 2005 .

A model for supporting and training clinical pharmaceutical scientist PhD students.

P. Kroboth, S. Poloyac, M. Tortorici, 2007, American journal of pharmaceutical education.

Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects

P. Kroboth, F. Kroboth, R. Juhl, 1982, Antimicrobial Agents and Chemotherapy.

Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing

P. Kroboth, J. McAuley, Randall B. Smith, 2005, Psychopharmacology.

Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects

P. Kroboth, R. Smith, 2005, Psychopharmacology.

Dysregulation of neurosteroids in obsessive compulsive disorder.

M. Folan, P. Kroboth, G. Haas, 2009, Journal of psychiatric research.

New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolam.

P. Kroboth, S. Cox, V. Schmith, 1991, Journal of chromatography.

Design and pharmacodynamic evaluation of novel dual release formulations of triazolam.

M. Folan, P. Kroboth, F. Kroboth, 1993, International journal of clinical pharmacology, therapy, and toxicology.

Roadmap to 2015: Preparing Competent Pharmacists and Pharmacy Faculty for the Future Combined Report of the 2005-06 Argus Commission and the Academic Affairs, Professional Affairs, and Research and Graduate Affairs Committees

Robert A. Kerr, P. McNamara, P. Kroboth, 2006 .

Getting to Solutions in Interprofessional Education: Report of the 2006-2007 Professional Affairs Committee

P. Kroboth, D. Robinson, M. Hogue, 2007 .

Effects of end‐stage renal disease and aluminum hydroxide on temazepam kinetics

P. Kroboth, J. Puschett, R. Rault, 1985, Clinical pharmacology and therapeutics.

Correlates and prevalence of benzodiazepine use in community-dwelling elderly

P. Kroboth, B. Psaty, R. Schulz, 1998, Journal of General Internal Medicine.

Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.

P. Kroboth, R. Bertz, R. Smith, 1993, The Journal of pharmacology and experimental therapeutics.

Conceptual Issues in Designing a Clinical Scientist Program

P. Kroboth, R. Juhl, 1987, Drug intelligence & clinical pharmacy.

Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.

D E Salazar, P. Kroboth, R. Dockens, 1995, Journal of clinical psychopharmacology.

responsiveness to resistance exercise in MERET Steroid sulfatase gene variation and DHEA

Robert E. Ferrell, Patricia D. Kroboth, Steven E. Riechman, 2013 .

Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques.

B. Pollock, P. Kroboth, R. Bies, 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Influence of DHEA Administration on 24-Hour Cortisol Concentrations

A. M. Linares, B. Pollock, R. Stone, 2003, Journal of clinical psychopharmacology.

Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.

F. Salek, P. Kroboth, I. Reynolds, 1997, The Journal of pharmacology and experimental therapeutics.

Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults

A. M. Linares, B. Pollock, B. Mulsant, 2001, Biological Psychiatry.

Progesterone: does it affect response to drug?

P. Kroboth, J. McAuley, 1997, Psychopharmacology bulletin.

Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients

R. Stone, P. Kroboth, A. Pittenger, 2001, Critical care medicine.

Comparison of Adinazolam Pharmacokinetics and Effects in Healthy and Cirrhotic Subjects

P. Kroboth, J. Fleishaker, Randall B. Smith, 1991, Journal of clinical pharmacology.

Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.

M. Folan, P. Kroboth, R. Lush, 1995, Journal of clinical psychopharmacology.

Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam.

P. Kroboth, R. Juhl, V. M. Daugherty, 1984, Clinical pharmacy.

Pharmacodynamic Modelling

R B Smith, P. Kroboth, V D Schmith, 1991, Clinical pharmacokinetics.

AACP Council of Deans Report, July 2011

P. Kroboth, J. Bradberry, R. Evans, 2011, American Journal of Pharmaceutical Education.

Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.

P. Kroboth, J. Puschett, K. Mitchum, 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phenytoin–Theophylline–Quinidine Interaction

P. Kroboth, R. Reed, H. Schwartz, 1983 .